secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIOGEN INC. (BIIB)
CIK:        0000875045
Form:       8-K
Filed at:   2023-12-12T23:59:59+00:00
Accession:  0001193125-23-293433
Event type: other
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Biogen amends bylaws to update stockholder notice requirements and align with SEC universal proxy rules
--------------------------------------------------------------------------------

- Requires disclosure of derivative/synthetic long positions from stockholders proposing business or nominations.
- Aligns director nomination procedures with Rule 14a-19, including 67% proxy solicitation representation requirement.
- Limits number of nominees a stockholder may propose to number of directors to be elected at meeting.
- Requires stockholder proxy solicitations to use non-white proxy cards; white cards reserved for Board use.
- Updates adjournment, quorum, and stockholder list provisions to conform to recent Delaware law changes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/875045/000119312523293433/0001193125-23-293433-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/875045/000119312523293433/d850833d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-293433

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer